NuVasive Inc.

NASDAQ: NUVA · Real-Time Price · USD
39.75
-0.91 (-2.24%)
At close: Aug 31, 2023, 10:00 PM

NuVasive Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
1.2B 1.14B
Cost of Revenue
336.51M 322.28M
Gross Profit
865.43M 816.71M
Operating Income
64.77M 31.39M
Interest Income
2.76M 160K
Pretax Income
52.32M -58.38M
Net Income
40.41M -64.09M
Selling & General & Admin
634.1M 610.09M
Research & Development
98.52M 92.63M
Other Expenses
49.38M 57.31M
Operating Expenses
782M 760.02M
Interest Expense
17.42M 21.06M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
1.12B 1.08B
Income Tax Expense
11.91M 5.7M
Shares Outstanding (Basic)
57.36M 51.59M
Shares Outstanding (Diluted)
57.36M 51.59M
EPS (Basic)
0.78 -1.24
EPS (Diluted)
0.76 -1.24
EBITDA
211.8M 180.91M
EBIT
1.7M -16.43M
Depreciation & Amortization
147.03M 149.52M